Dcm Advisors, LLC Amgen Inc Transaction History

Dcm Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $588,110 - $663,458	2,300 New	2,300 $662,000
Q4 2022 Sep 08, 2023	SELL	$229.03 - $291.01 $691,899 - $879,141	-3,021 Closed	0 $0
Q3 2022 Sep 08, 2023	SELL	$224.46 - $253.15 $83,948 - $94,678	-374 Reduced 11.02%	3,021 $680,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $783,260 - $871,632	3,395 New	3,395 $827,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.